The brain has long been considered somewhat walled off from the immune system. New research reveals a surprising line of defense hiding in plain sight: immune outposts within the skull’s bone marrow that respond to brain cancer.
Researchers at Washington University School of Medicine, led by Jonathan Kipnis with first author Jang Hyun Park, identified lymph-node-like immune structures in skull bone marrow — containing T follicular helper cells and antibody-making B cells — connected to the brain through the dura mater’s lymphatic vessels and physical channels. The findings were published in Nature.
An early-warning system
In glioblastoma (an aggressive brain cancer) models, these skull immune hubs mounted rapid responses before distant lymph nodes detected the tumor. When researchers disrupted the hubs, tumors grew faster and survival fell — evidence the structures actively help fight cancer. Similar immune cells were also found in human skull bone marrow.
Turning it into therapy
The team tested a gel containing three immune-boosting signals (a CD40 agonist, IL-21 and interferon-gamma) applied under the scalp. Treated mice showed better tumor rejection and longer survival. Kipnis said the work “fundamentally change[s] our current understanding of neuroimmunology,” with possible implications beyond cancer, including Alzheimer’s and Parkinson’s. The results are preclinical, but they suggest a novel, accessible route to boosting brain-cancer immunity.